Tert-Butyl Formate

Tert-Butyl Formate

SCHEMBL28065009

CC(C)(C)OC=O.OCC1CCNC(c2ccccc2)C1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 6/20 0.34
MAOB P27338 4/20 0.34
MAOA P21397 2/20 0.34
CHRNA7 P36544 1/20 0.34
S1PR4 O95977 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
S1PR5 Q9H228 1/20 0.33
SLC18A3 Q16572 1/20 0.33
SLC6A2 P23975 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
GBA1 P04062 1/20 0.31
RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tert-Butyl Formate SCHEMBL28065028 0.85 CFB (0.33) KDM1AMAOBMAOACHRNA7
SCHEMBL16400486 0.84 KDM1A (0.42) KDM1AMAOBMAOACHRNA7SLC18A3
SCHEMBL2707339 0.84 KDM1A (0.42) KDM1AMAOBMAOACHRNA7SLC18A3
Tert-Butyl Formate SCHEMBL28065029 0.81 TDP1 (0.34) KDM1AMAOBMAOASLC6A2TDP1
SCHEMBL30661773 0.75 KDM1A (0.39) KDM1AMAOBMAOACHRNA7SLC6A2
SCHEMBL27869789 0.74 SLC6A1 (0.42) KDM1AMAOBMAOACHRNA7S1PR4
SCHEMBL28065007 0.74 CHRM3 (0.38) KDM1AMAOACHRNA7CHRM2CHRM1
Tert-Butyl Formate SCHEMBL27790496 0.74 TDP1 (0.37) SLC18A3TDP1
Tert-Butyl Formate SCHEMBL27591602 0.74 TDP1 (0.46) KDM1AMAOATDP1GBA1
SCHEMBL27915958 0.73 CHRNA7 (0.44) KDM1AMAOBMAOACHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105579444-A Piperidinylindole derivatives and their use as complement factor B inhibitors NOVARTIS AG 2016-05-11 CN disclosed